InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by...
Stay updated with breaking news from Johan Gil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by...
Today announced that the company will be exhibiting at the Digestive Disease Week (DDW) May 21-24, 2022 in...
STOCKHOLM, May 12, 2022 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company will be exhibiting at the Digestive Disease Week (DDW) May 21-24, 2022 in San
STOCKHOLM, April 28, 2022 /PRNewswire/ -- Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820 (the "Company"), are hereby summoned to the Annual General Meeting on Wednesday
/PRNewswire/ -- Shareholders in InDex Pharmaceuticals Holding AB, reg. nr 559067-6820 (the "Company"), are hereby summoned to the Annual General Meeting on...